According to Smith & Nephew
's latest financial reports the company has a price-to-book ratio of 2.11.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 2.28 | 2.58% |
2022-12-31 | 2.23 | -19.3% |
2021-12-31 | 2.76 | -19.31% |
2020-12-31 | 3.42 | -17.37% |
2019-12-31 | 4.14 | 22.25% |
2018-12-31 | 3.38 | 3.8% |
2017-12-31 | 3.26 | -1.77% |
2016-12-31 | 3.32 | -17.96% |
2015-12-31 | 4.05 | -1.12% |
2014-12-31 | 4.09 | 30.65% |
2013-12-31 | 3.13 | 22.52% |
2012-12-31 | 2.56 | -5.35% |
2011-12-31 | 2.70 | -19.96% |
2010-12-31 | 3.37 | -19.07% |
2009-12-31 | 4.17 | 24.13% |
2008-12-31 | 3.36 | -40.72% |
2007-12-31 | 5.67 | 24.73% |
2006-12-31 | 4.54 | -25.25% |
2005-12-31 | 6.08 | -56.03% |
2004-12-31 | 13.8 | 7.71% |
2003-12-31 | 12.8 | -6.22% |
2002-12-31 | 13.7 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 5.15 | 144.65% | ๐บ๐ธ USA |
Boston Scientific BSX | 5.40 | 156.58% | ๐บ๐ธ USA |
Edwards Lifesciences EW | 7.33 | 248.19% | ๐บ๐ธ USA |
Stryker Corporation SYK | 6.57 | 212.27% | ๐บ๐ธ USA |
Orthofix Medical
OFIX | 0.9083 | -56.86% | ๐บ๐ธ USA |
CONMED CNMD | 2.53 | 20.41% | ๐บ๐ธ USA |